One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent☆,☆☆
Keywords
Cited by (0)
- ☆
Grant support: The Academic Medical Center – University of Amsterdam received an unrestricted research grant from OrbusNeich BV.
- ☆☆
Potential conflict of interest: Dr. den Heijer is a consultant for Medtronic CoreValve and Direct Flow Medical. Dr. Menown has received grant support from Boston Scientific and Biosensors. Dr. van 't Hof has received grant support from The Medicines Company and Abbott Laboratories. Dr. de Winter has received grant support from OrbusNeich, Abbott Laboratories, AstraZeneca, Stentys, and Tryton; and consults for OrbusNeich. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- 1
All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.